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Background
Intravenous iron-supplementation drugs are frequently
used for treatment of iron-deficiency anemia in chronic
kidney disease. Some iron-agents alter tissue T1-relaxa-
tion times (T1) for days after administration, and could
obscure MRI diagnosis. Conversely, these agents may
have the potential to delineate pathology. We sought to
investigate the T1-shortening effect of ferumoxytol and
iron-dextran, determine h o wT 1o fb l o o d ,l i v e r ,a n d
myocardium change over time in-vivo after iron admin-
istration, and explore the utility of these agents for ima-
ging acute myocardial infarction (MI).
Methods
We determined in-vitro T1 of ferumoxytol and iron-
dextran (20mg Fe ad 500ml 0.9%NaCl). Seven dogs with
acute, reperfused MI were scanned five days later on a
3.0T MRI-scanner, at which time ferumoxytol (n=5) or
iron-dextran (n=2) was administered in clinically used
doses (approx. 130mg iron). Inversion-recovery, gradi-
ent-echo images with various inversion-times (115-
1600ms) were acquired prior to and serially after iron-
injection at multiple time-points on day 1 (n=7), 2
(n=5), 3 (n=2), and 7 (n=7). T1 was determined by stan-
dard curve-fitting.
Results
In-vitro T1 of ferumoxytol and iron-dextran were 13%
and 89% of 0.9%NaCl, respectively. T1 of blood, myocar-
dium, and liver were 2027±421ms, 1384±143ms, and
806±74ms, respectively. Results for ferumoxytol were:
T1 of blood dropped to 7% (p<0.001) 29±24min after
ferumoxytol-injection, and fully recovered by day 2 in 3/
5, and by day 7 in all animals. T1 of liver dropped to
36% (p<0.001) at 29±24min; notably, beyond 2 hours
and still present at 1 week, liver-signal was attenuated
by T2*-effects, which precluded calculation of T1. T1 of
normal myocardium dropped to 51% (p<0.001) at 39.1
±21.6min, and completely recovered by day 7 in all ani-
mals. Kinetics of ferumoxytol in MI was heterogenous,
when T1 of normal myocardium was shortest, T1 of MI
was the same or longer in all animals. At 2-5 hours, T1
of MI was shorter than myocardium in 3/5, longer in 1/
5 (with no-reflow), and same in 1/5 animals (small MI).
Based on differential kinetics of ferumoxytol in MI and
normal myocardium, acute MI was visualized at some
time-point in all animals. T1 for all tissues were similar
before and after iron-dextran (p>0.05).
Conclusions
Ferumoxytol may affect cardiovascular MR beyond 2
days and liver MR beyond 1 week after administration
of doses used clinically for iron-deficiency anemia.
Unless recognized, this could affect MRI diagnosis. The
differential kinetics suggest a potential use of ferumoxy-
tol for delineation of acute MI.
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Figure 1 Time course of T1-times in 5 animals, that received
ferumoxytol. * T1 of liver is reduced early after ferumoxytol, but
after 2 hours, the extent of T1 reduction cannot be determined due
to T2*-effects.
Figure 2 Pathology (a) and delayed enhancement image (b) 4:33 hrs after administration of ferumoxytol in an animal with acute infarction in
the LAD (arrow).
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